Effectiveness of Evusheld in Immunocompromised Patients: Propensity Score–Matched Analysis

Abstract

This study suggests that Evusheld is effective in reducing the risk of SARS-CoV-2 infection and COVID-19 hospitalization in immunocompromised patients. The effectiveness of this dose appears to be greater in nonobese patients.